First MNC Drug Retailer To Enter China Restructures Operation
This article was originally published in PharmAsia News
Medicine Shoppe, the first MNC drug retailer to enter China five years ago, is restructuring in response to difficulty in developing the market. It is closing down its eastern branch, and will be focusing on the country's eastern and southern regions this year. The company has adopted a franchise model to accelerate its market entry but faces shortcomings amidst intense competition. Medicine Shoppe plans to step up brand marketing and raise standards for new franchisees. It will now concentrate on penetrating deeper into the market it currently operates in rather than expanding into new cities. (Click here for more - Chinese Language
You may also be interested in...
A more conservative US Supreme Court may mean a less authoritative FDA, and drug pricing won’t get as much attention in the presidential campaign, which is a good thing.
The US HHS played defense on 20 September, pushing back on suggestions that secretary Alex Azar’s recent move to exert control over regulations by signing off on them was a power play aimed at the FDA. Meanwhile, former agency head Scott Gottlieb says it’s “the wrong move at the wrong time.”
With list due 4 November, there may not be time for public comment. Meanwhile, where will biopharma find fill/finish capacity?